Chimeric Therapeutics Ltd (chm) Logo

Chimeric Therapeutics Ltd (CHM)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

CHM ASX Chart

Snapshot

Chimeric Therapeutics Limited (CHM) is a clinical stage cell therapy company and an Australian leader in cell therapy and is is focused on bringing the promise of cell therapy to life for more patients with cancer. Chimeric's team of cell therapy pioneers and experts is focused on the discovery, development, and commercialization of the innovative and promising cell therapies. Chimeric currently has a diversified portfolio that includes two autologous CAR T cell therapies and allogeneic NK cell therapies

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -54.93%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,580 of 2,383
Sector Rank 148 of 227

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies OSL / AC8 / MXC
EPS -$0.027
DPS $0.00
Book Value Per Share -$0.009

Broker Consensus

CHM is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Carlton South VIC 3053
Website www.chimerictherapeutics.com
Registry BoardRoom
Auditor Grant Thornton Audit Pty Ltd
Date Listed 18 Jan 2021

Upcoming Calendar (Forecasted)

Date Event
29/08/2024 Report (Prelim)
26/09/2024 Report (Annual)
27/02/2025 Report (Interim)

Former Company Names

  • Chimeric Therapeutics Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

CHM directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
14/12/23 Eric Sullivan Issued 2,750,000 $0.027 $74,250 Issue of options
14/12/23 Jennifer Chow Issued 8,643,603 $0.035 $302,526 Issue of securities
14/12/23 Jennifer Chow Issued 15,139,467 $0.027 $408,765 Issue of options
14/12/23 Jennifer Chow Issued 4,062,997 $0.027 $109,700 Issue of securities
07/12/23 Phillip Hains Issued 3,571,429 $0.028 $100,000 Rights issue
12/07/23 Lesley Russell Issued 1,739,130 $0.046 $79,999 Placement
12/07/23 Jennifer Chow Issued 108,695 $0.046 $4,999 Placement
12/07/23 George Matcham Issued 1,086,956 $0.046 $49,999 Placement
12/07/23 Cynthia Elkins Issued 108,695 $0.046 $4,999 Placement
12/07/23 Paul Hopper Issued 13,043,478 $0.046 $599,999 Placement
12/07/23 Leslie (Mi Ok) Chong Issued 108,695 $0.046 $4,999 Placement
23/06/23 Paul Hopper Buy +857,142 $0.035 $29,999 Participation in share purchase plan
12/12/22 Jennifer Chow Issued 3,300,325 $0.089 $293,728 Issue of securities
18/11/22 Jennifer Chow Issued 4,338,990 $0.092 $399,187 Issue of securities
18/11/22 Jennifer Chow Issued 17,222,368 $0.087 $1,498,346 Issue of options
04/07/22 George Matcham Buy +342,070 $0.098 $33,522 On-market trade
29/06/22 Leslie (Mi Ok) Chong Buy +30,000 $0.098 $2,940 On-market trade
25/03/22 Leslie (Mi Ok) Chong Issued 3,905 $0.150 $585 Rights issue
25/03/22 Leslie (Mi Ok) Chong Issued 3,905 $0.170 $663 Rights issue
25/03/22 Paul Hopper Issued 2,941,176 $0.150 $441,176 Rights issue
25/03/22 Cynthia Elkins Issued 7,873 $0.150 $1,180 Rights issue
25/03/22 Cynthia Elkins Issued 7,873 $0.170 $1,338 Rights issue
25/03/22 George Matcham Issued 158,730 $0.017 $2,698 Rights issue
25/03/22 George Matcham Issued 158,730 $0.150 $23,809 Rights issue
25/03/22 George Matcham Transfer 500,000 $0.150 $75,000 Off-market transfer
25/03/22 George Matcham Transfer 500,000 $0.150 $75,000 Off-market transfer
01/03/22 Paul Hopper Issued 2,941,176 $0.170 $499,999 Rights issue
03/12/21 George Matcham Issued 2,750,000 $0.260 $715,000 Issue of options
03/12/21 Cynthia Elkins Issued 2,750,000 $0.260 $715,000 Issue of options
03/12/21 Jennifer Chow Issued 2,000,000 $0.260 $520,000 Issue of options
03/12/21 Jennifer Chow Issued 1,032,416 $0.272 $280,817 Issue of securities
03/12/21 Paul Hopper Buy +375,000 $0.262 $98,437 On-market trade
04/08/21 George Matcham Buy +500,000 $0.332 $166,000 On-market trade
08/03/21 Cynthia Elkins Buy +24,800 $0.318 $7,881 On-market trade
29/01/21 Leslie (Mi Ok) Chong Buy +7,300 $0.326 $2,378 On-market trade
20/01/21 Leslie (Mi Ok) Chong Buy +5,000 $0.390 $1,950 On-market trade

Director Interests

The current holdings of CHM directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Paul Hopper 31/03/2024 375,000 80,718,954 0 N/A
Phillip Hains 31/03/2024 N/A 10,326,028 0 N/A
Eric Sullivan 14/12/2023 0 N/A 2,750,000 N/A
Jennifer Chow 14/12/2023 1,702,914 16,282,918 42,653,330 N/A
Lesley Russell 28/09/2023 N/A N/A 2,750,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 21, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Paul Hopper 94,994,574 17.94%
Lind Global Fund II LP 17,624,724 3.33%
Christine Brown 11,696,565 2.21%
Michael E Barish 11,522,634 2.18%
Zerrin Investments Pty Ltd 9,600,001 1.81%
Jennifer Chow 9,450,924 1.79%
Hsbc Custody Nominees (Australia) Limited 9,437,237 1.78%
Citicorp Nominees Pty Limited 8,540,926 1.61%
Shared Office Services Pty Ltd <Philanne S/F A/C> 6,521,739 1.23%
Valentino Trading Pty Ltd 5,500,000 1.04%
Kamala Holdings Pty Ltd <The Kamala 1994 S/F A/C> 5,447,142 1.03%
Australian Direct Investments Pty Limited <Super Fund A/C> 5,060,000 0.96%
Liberty National Pty Ltd <Liberty National Family A/C> 5,000,000 0.94%
Ubs Nominees Pty Ltd 4,945,588 0.93%
Mr Lutz Steffens & Mrs Katy Steffens 4,303,341 0.81%
Solium Nominees (Australia) Pty Ltd 4,087,272 0.77%
Mr Tim Bensley & Ms Jenny Jiaer Zhang 3,961,562 0.75%
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,655,335 0.69%
Alpha Beta Superannuation Services Pty Ltd <The Alpha Beta Sf A/C> 3,357,142 0.63%
Brispot Nominees Pty Ltd <House Head Nominee A/C> 3,243,205 0.61%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 53 879 501 1,554 648 3,635

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Paul Hopper 21/09/2023 94,137,432 17.78

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
12-07-23 Paul Hopper 13,043,478 21.40 17.78

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.038 30 June
2022 $0.092 30 June
2021 $0.290 30 June
CHM Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.